Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | VEGFR1-1084 |
Synonyms | |
Therapy Description |
VEGFR1-1084 is a FLT1 (VEGFR1) HLA-A*2402 allele-restricted peptide vaccine, which may stimulate a cytotoxic T-cell response against cells expressing FLT1 (VEGFR1), resulting in decreased tumor angiogenesis (PMID: 17020992, NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
VEGFR1-1084 | VEGFR1-A24-1084|OTS11101 | VEGFR1-1084 is a FLT1 (VEGFR1) HLA-A*2402 allele-restricted peptide vaccine, which may stimulate a cytotoxic T-cell response against cells expressing FLT1 (VEGFR1), resulting in decreased tumor angiogenesis (PMID: 17020992, NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|